Free Trial

Mettler-Toledo International (MTD) Stock Forecast & Price Target

Mettler-Toledo International logo
$1,182.55 +5.46 (+0.46%)
Closing price 03/31/2025 03:59 PM Eastern
Extended Trading
$1,179.07 -3.48 (-0.29%)
As of 03/31/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mettler-Toledo International - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
6
Buy
2

Based on 9 Wall Street analysts who have issued ratings for Mettler-Toledo International in the last 12 months, the stock has a consensus rating of "Hold." Out of the 9 analysts, 1 has given a sell rating, 6 have given a hold rating, and 2 have given a buy rating for MTD.

Consensus Price Target

$1,380.50
16.74% Upside
According to the 9 analysts' twelve-month price targets for Mettler-Toledo International, the average price target is $1,380.50. The highest price target for MTD is $1,475.00, while the lowest price target for MTD is $1,250.00. The average price target represents a forecasted upside of 16.74% from the current price of $1,182.55.
Get the Latest News and Ratings for MTD and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Mettler-Toledo International and its competitors.

Sign Up

MTD Analyst Ratings Over Time

TypeCurrent Forecast
4/1/24 to 4/1/25
1 Month Ago
3/2/24 to 3/2/25
3 Months Ago
1/2/24 to 1/1/25
1 Year Ago
4/2/23 to 4/1/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
7 Hold rating(s)
2 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$1,380.50$1,368.00$1,351.25$1,223.71
Forecasted Upside16.74% Upside7.59% Upside10.43% Upside-8.76% Downside
Consensus Rating
Hold
Hold
Hold
Hold
Remove Ads

MTD Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MTD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Mettler-Toledo International Stock vs. The Competition

TypeMettler-Toledo InternationalMedical CompaniesS&P 500
Consensus Rating Score
2.11
2.82
2.54
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside16.74% Upside19,269.98% Upside19.03% Upside
News Sentiment Rating
Very Positive News

See Recent MTD News
Positive News
Positive News
Remove Ads
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/4/2025Citigroup
3 of 5 stars
P. Donnelly
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$1,450.00 ➝ $1,400.00+12.72%
2/10/2025Evercore ISI
2 of 5 stars
V. Kumar
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$1,450.00 ➝ $1,475.00+9.12%
2/10/2025Wells Fargo & Company
3 of 5 stars
B. Couillard
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$1,350.00 ➝ $1,400.00+1.97%
2/10/2025Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Catherine Schulte
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$1,362.00 ➝ $1,369.00-1.51%
12/13/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Schenkel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoveragePeer Perform
11/11/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$1,550.00 ➝ $1,450.00+13.50%
8/5/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$1,300.00 ➝ $1,400.00+0.56%
7/9/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$1,150.00 ➝ $1,300.00-1.41%
6/3/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHold ➝ Underperform$1,230.00 ➝ $1,250.00-10.97%
5/8/202351job
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
5/7/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$1,650.00 ➝ $1,525.00+7.02%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 04:48 AM ET.


Should I Buy Mettler-Toledo International Stock? MTD Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, March 28, 2025. Please send any questions or comments about these Mettler-Toledo International pros and cons to contact@marketbeat.com.

Mettler-Toledo International
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Mettler-Toledo International Inc.:

  • The company recently reported earnings per share (EPS) of $12.41, exceeding analysts' expectations of $11.76, indicating strong financial performance.
  • Mettler-Toledo International Inc. has a solid market capitalization of approximately $25.25 billion, reflecting its stability and growth potential in the medical instruments sector.
  • The stock price is currently around $1,211.71, showing resilience and a potential for appreciation given its 1-year high of $1,546.93.
  • Institutional investors own 95.07% of the company's stock, suggesting strong confidence from major financial entities in Mettler-Toledo International Inc.'s future prospects.
  • The company has a net margin of 22.29%, which indicates effective cost management and profitability, making it an attractive option for investors seeking solid returns.

Mettler-Toledo International
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Mettler-Toledo International Inc. for these reasons:

  • The company has a negative return on equity of 591.54%, which may raise concerns about its ability to generate profit from shareholders' equity.
  • Despite recent performance, the stock has experienced fluctuations, with a recent decline of 1.3%, indicating potential volatility in the market.
  • The price-to-earnings (P/E) ratio is currently at 29.90, which may suggest that the stock is overvalued compared to its earnings, potentially deterring value-focused investors.
  • Recent trading volumes have been lower than average, which could indicate reduced investor interest or liquidity issues in the stock.
  • With a price-to-earnings-growth (P/E/G) ratio of 3.30, the stock may not be as attractive for growth investors looking for better value opportunities.

MTD Forecast - Frequently Asked Questions

According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Mettler-Toledo International is $1,380.50, with a high forecast of $1,475.00 and a low forecast of $1,250.00.

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Mettler-Toledo International in the last year. There is currently 1 sell rating, 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" MTD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MTD, but not buy additional shares or sell existing shares.

According to analysts, Mettler-Toledo International's stock has a predicted upside of 16.74% based on their 12-month stock forecasts.

Over the previous 90 days, Mettler-Toledo International's stock had 1 upgrade by analysts.

Mettler-Toledo International has been rated by research analysts at Citigroup, Evercore ISI, Robert W. Baird, and Wells Fargo & Company in the past 90 days.

Analysts like Mettler-Toledo International less than other "medical" companies. The consensus rating for Mettler-Toledo International is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how MTD compares to other companies.


This page (NYSE:MTD) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners